News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|September 22, 2016 (Updated: November 15, 2020)

Managing Medication Adherence to Improve Clinical Trial Quality

Author(s)Sponsor's Content
Advertisement
External Link - Advanstar westrock Managing Medication Adherence (1).pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement

Consent‑Driven Targeting: Building Trust With Patients and HCPs

ByKevin King
March 5th 2026
Stock.adobe.com

Three Imperatives Pharma Leaders Should Prioritize This Year

BySarah Rickwood
March 5th 2026
Stock.adobe.com

Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds

ByNicholas Jacobus
March 5th 2026
Stock.adobe.com

Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing

ByNicholas Jacobus
March 5th 2026
Artificial intelligence (AI), particularly large language models (LLMs) and natural language processing (NLP), is revolutionizing the analysis of pharmaceutical safety data. Credit: Stock.Adobe.com/Sikov.

Transforming Drug Safety Through Artificial Intelligence, Large Language Models

ByPartha Anbil,Niraj Patel
March 5th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options

2

Pharmaceutical Executive Daily: Pharma Industry's AI Adoption

3

The Ongoing Impact of MFN Pricing

4

AI's Inflection Point: Bridging the Adoption and ROI Gap

5

Technological Renaissance: AI’s Integration into the Pharmaceutical Industry

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us